» Articles » PMID: 25522406

Schizophrenia Gene Expression Profile Reverted to Normal Levels by Antipsychotics

Overview
Specialty Psychiatry
Date 2014 Dec 19
PMID 25522406
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite the widespread use of antipsychotics, little is known of the molecular bases behind the action of antipsychotic drugs. A genome-wide study is needed to characterize the genes that affect the clinical response and their adverse effects.

Methods: Here we show the analysis of the blood transcriptome of 22 schizophrenia patients before and after medication with atypical antipsychotics by next-generation sequencing.

Results: We found that 17 genes, among the 21 495 genes analyzed, have significantly-altered expression after medication (p-value adjusted [Padj] <0.05). Six genes (ADAMTS2, CD177, CNTNAP3, ENTPD2, RFX2, and UNC45B) out of the 17 are among the 200 genes that we characterized with differential expression in a previous study between antipsychotic-naïve schizophrenia patients and controls (Sainz et al., 2013). This number of schizophrenia-altered expression genes is significantly higher than expected by chance (Chi-test, Padj 1.19E-50), suggesting that at least part of the antipsychotic beneficial effects is exerted by modulating the expression of these genes. Interestingly, all six of these genes were overexpressed in patients and reverted to control levels of expression after treatment. We also found a significant enrichment of genes related to obesity and diabetes, known adverse affects of antipsychotics.

Conclusions: These results may facilitate understanding of unknown molecular mechanisms behind schizophrenia symptoms and the molecular mechanisms of antipsychotic drugs.

Citing Articles

Inferring DNA methylation in non-skeletal tissues of ancient specimens.

Mathov Y, Nissim-Rafinia M, Leibson C, Galun N, Marques-Bonet T, Kandel A Nat Ecol Evol. 2024; 9(1):153-165.

PMID: 39567757 PMC: 11726462. DOI: 10.1038/s41559-024-02571-w.


Patients with schizophrenia and bipolar disorder display a similar global gene expression signature in whole blood that reflects elevated proportion of immature neutrophil cells with association to lipid changes.

Torsvik A, Brattbakk H, Trentani A, Holdhus R, Stansberg C, Bartz-Johannessen C Transl Psychiatry. 2023; 13(1):147.

PMID: 37147304 PMC: 10163263. DOI: 10.1038/s41398-023-02442-1.


Antipsychotic drug use complicates assessment of gene expression changes associated with schizophrenia.

Schulmann A, Marenco S, Vawter M, Akula N, Limon A, Mandal A Transl Psychiatry. 2023; 13(1):93.

PMID: 36932057 PMC: 10023659. DOI: 10.1038/s41398-023-02392-8.


Integrative Analyses of Transcriptomes to Explore Common Molecular Effects of Antipsychotic Drugs.

Truong T, Bortolasci C, Kidnapillai S, Spolding B, Panizzutti B, Liu Z Int J Mol Sci. 2022; 23(14).

PMID: 35886854 PMC: 9325239. DOI: 10.3390/ijms23147508.


Receptor-Mediated AKT/PI3K Signalling and Behavioural Alterations in Zebrafish Larvae Reveal Association between Schizophrenia and Opioid Use Disorder.

Thiagarajan S, Mok S, Ogawa S, Parhar I, Tang P Int J Mol Sci. 2022; 23(9).

PMID: 35563106 PMC: 9104710. DOI: 10.3390/ijms23094715.


References
1.
McEwen B, Alves S . Estrogen actions in the central nervous system. Endocr Rev. 1999; 20(3):279-307. DOI: 10.1210/edrv.20.3.0365. View

2.
Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T . Serum osteocalcin/bone-specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes. Calcif Tissue Int. 2009; 85(3):228-34. DOI: 10.1007/s00223-009-9272-4. View

3.
Chana G, Bousman C, Money T, Gibbons A, Gillett P, Dean B . Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. Front Cell Neurosci. 2013; 7:95. PMC: 3693064. DOI: 10.3389/fncel.2013.00095. View

4.
Czermak C, Lehofer M, Renger H, Wagner E, Lemonis L, Rohrhofer A . Dopamine receptor D3 mRNA expression in human lymphocytes is negatively correlated with the personality trait of persistence. J Neuroimmunol. 2004; 150(1-2):145-9. DOI: 10.1016/j.jneuroim.2004.01.009. View

5.
Lasky-Su J, Anney R, Neale B, Franke B, Zhou K, Maller J . Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B(8):1355-8. PMC: 2605611. DOI: 10.1002/ajmg.b.30869. View